Ewing's sarcoma natural history: Difference between revisions
Created page with "{{Ewing's sarcoma}} {{CMG}}; '''Assistant Editor(s)-In-Chief:''' Michael Maddaleni, B.S. ==Overview== ==Natural History== ==Prognosis== ==Compli..." |
|||
| Line 7: | Line 7: | ||
==Prognosis== | ==Prognosis== | ||
Staging attempts to distinguish patients with localized from those with [[metastasis|metastatic]] disease. Most commonly, [[metastasis|metastases]] occur in the chest, bone and/or bone marrow. Less common sites include the [[central nervous system]] and [[lymph node]]s. | |||
Survival for localized disease is 65-70% when treated with [[chemotherapy]]. Long term survival for [[metastasis|metastatic]] disease can be less than 10% but some sources state it is 25-30%. | |||
==Complications== | ==Complications== | ||
Revision as of 20:47, 7 December 2011
|
Ewing's sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ewing's sarcoma natural history On the Web |
|
American Roentgen Ray Society Images of Ewing's sarcoma natural history |
|
Risk calculators and risk factors for Ewing's sarcoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: Michael Maddaleni, B.S.
Overview
Natural History
Prognosis
Staging attempts to distinguish patients with localized from those with metastatic disease. Most commonly, metastases occur in the chest, bone and/or bone marrow. Less common sites include the central nervous system and lymph nodes.
Survival for localized disease is 65-70% when treated with chemotherapy. Long term survival for metastatic disease can be less than 10% but some sources state it is 25-30%.